The global infertility treatment market size was valued at US$ 1.5 Billion in 2021 and is forecast to grow at a robust CAGR of 8% between 2022 and 2032, surpassing a valuation of US$ 3.5 Billion by the end of 2032. Growth in the infertility treatment market is driven by rising infertility rates across the globe and the growing popularity of advanced infertility treatments such as assisted reproductive technology.
| Data Points | Market Insights |
|---|---|
| Infertility Treatment Market Value 2021 | USD 1.5 Billion |
| Infertility Treatment Market Value 2026 | USD 2.2 Billion |
| Infertility Treatment Market Projected Value 2032 | USD 3.5 Billion |
| Infertility Treatment Market Forecast CAGR (2022-2032) | 8.0% |
| Key Players | Thermo Fisher Scientific (USA), Cook Group (USA), Vitrolife (Sweden), IVFtech APS (Denmark), Hamilton Thorne Ltd. (USA), Esco Micro Pte Ltd. (Singapore), Genea Biomedx Ltd. (Australia), FUJIFILM Irvine Scientific (USA), and the Baker Company INC. (USA) |
With global rates of male and female infertility continuing to rise drastically, demand for infertility treatments is slated to grow at a healthy pace during the forecast period. People who are unable to conceive naturally are opting for infertility treatments like artificial insemination assisted reproductive technology, and fertility surgeries.
Over the years, there has been a significant rise in the number of fertility clinics and hospitals across the globe that provide a wide range of advanced reproductive technologies to sterile people and help them to conceive children.
The inability to produce children can lead to emotional disturbance, depression, and several other serious consequences. As a result, people with infertility problems are increasingly opting for assisted reproductive technology procedures. Rising awareness about the benefits of these reproductive technologies will continue to encourage their adoption during the forecast period. It is estimated that over 5 million children worldwide are born from ART intervention as per the World Health Organization (WHO).
Similarly, the growing popularity of stem cell-based therapies for the treatment of male infertility and increasing investments in research and development activities for exploring novel approaches for infertility treatment will boost market growth during the forthcoming years. For instance, in 2021 research at the University of Georgia successfully developed sperm cells from primate cells that provides hope for future clinical therapies.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for infertility treatments is slated to grow at a healthy CAGR of 8% during the forecast period between 2022 and 2032. Factors such as the declining global fertility rate, the surge in the number of infertility centers, the higher success rate of advanced reproductive technologies, growing medical tourism, and increasing support from the government and other healthcare organizations are driving growth in the global infertility treatment market.
Infertility treatments are reproductive medical techniques and procedures employed to help people achieve pregnancy when natural conception is not feasible. They have been in use for a long time now. However, the introduction of assisted reproductive technology (ART) has completely transformed the global infertility treatment market in recent years. Today, most people who are not able to conceive naturally opt for advanced reproductive technologies like in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), and intracytoplasmic sperm injection due to their higher success rates.
The rapid decline in global fertility rates due to factors such as excessive usage of contraceptives, delayed marriages, the presence of various diseases, etc., is acting as a catalyst for the growth of the infertility treatment market. According to the World Fertility and Family Planning 2020 report of the Population Division of the United Nations Department of Economic and Social Affairs (UN DESA), the global fertility rate is expected to continue to fall from 2.5 live births per woman today to 2.2 in 2050. This will continue to expand the infertility treatment market size during the forthcoming years.
Growing health awareness is another factor augmenting the infertility treatment market growth. Leading market players and healthcare organizations are continuously putting efforts into educating the masses about infertility, its consequences, and the availability of various treatments. For instance, Oasis Fertility launched a new online portal for IVF treatment. Similarly, in 2021 EMD Serono launched a new fertility LifeLines Portal to increase support and access for patients with infertility.
Similarly, the rapid growth of cryopreservation for the in-vitro fertilization (IVF) market, rising infertility testing rates, and booming medical tourism sector will create opportunities for infertility treatment companies during the forecast period.
Developing countries like China and India are experiencing huge demand for infertility treatments due to the availability of low-cost IVF treatment and ICSI treatments. Growing medical tourism across these countries will eventually increase the infertility treatment devices market share during the forecast period.
Despite a positive growth outlook, the global infertility treatment market is facing various challenges that are slowing down its growth to some extent. Some of these challenges are the high cost of assisted reproductive technology (ART) procedures, the lack of reimbursement policies across the majority of the regions, ethical considerations and limitations on ART procedures, and the presence of stringent regulations on the use of ART.
Principal Consultant
Decreasing Fertility Rate Creating Growth Prospects for Infertility Treatment Market in the United Kingdom
As per Future Market Insights, the United Kingdom will continue to remain the most lucrative market for infertility treatments, owing to the declining fertility rate, the heavy presence of leading infertility treatment clinics and highly qualified professionals, the growing popularity of assisted reproductive technology due to its higher success rate, and flourishing surrogacy tourism.
Over the years, there has been a rapid decline in the fertility rate across the United Kingdom which in turn is creating space for infertility treatment market growth. According to Office for National Statistics, the total fertility rate (TFR) reached a record low of 1.59 children per woman in England in 2020.
Similarly, heavy penetration of infertility treatment clinics and IVF centers across the United Kingdom is boosting the growth of the infertility treatment market and the trend is likely to continue in the future.
Rising Adoption of Assisted Reproductive Technology Spurring Infertility Treatment Market Growth in the USA
The USA infertility treatment market is poised to exhibit strong growth during the forecast period from 2022 to 2032, owing to the rising cases of infertility due to polycystic ovary syndrome (PCOS), the rapidly evolving healthcare industry, easy availability of in vitro fertilization banking services, presence of leading market players, growing adoption of advanced technologies, and rapid expansion of donor egg IVF (in-vitro fertilization) market.
The rising prevalence of POCS cases in the USA has resulted in an increase in infertility rates across the USA As per the Centers for Disease Control and Prevention (CDC), PCOS is one of the most common causes of female infertility in the USA affecting 6% to 12% of women of reproductive age. This will continue to generate demand for infertility treatments, thereby boosting the growth of the USA IVF market during the forecast period.
Similarly, the growing adoption of assisted reproductive techniques such as IVF and GIFT due to their higher success rates is augmenting the growth of the infertility treatment market in the USA Each year thousands of infants born in the USA are conceived by using ART.
Demand for Media and Consumables Will Continue to Remain High in the Global Infertility Treatment Market
Based on product, the global infertility treatment market has been segmented into equipment, media & consumables, and accessories. Among these, the media & consumable segment accounts for the largest share of the infertility treatment market. This is attributed to growing consumer preference for infertility treatment drugs as the first line of treatment due to their easy availability and low-cost nature. Similarly, increasing usage of different types of media to culture embryos coupled with the expansion of IVF devices and the consumables market will further boost the growth of this segment during the forecast period.
High Success Rate of Assisted Reproductive Technology Encouraging its Adoption
By procedure, the infertility treatment market is segmented into assisted reproductive technology, artificial insemination, fertility surgeries, and others. Among these, artificial insemination held a significant share of the global infertility treatment market in 2020. However, with advancements in reproductive technology and rising consumer inclination towards treatments like in vitro fertilization due to their various advantages, the assisted reproductive technology (ART) segment is expected to outpace the artificial insemination segment during the forecast period.
People are increasingly opting for assisted reproductive technology on account of its higher success rate and rising institutional financial support. As per the Centers for Disease Control and Prevention (CDC), nearly 2.1% of all infants born in the USA every year are conceived using assisted reproduction technology. Driven by this, the latest infertility treatment market trends indicate that the ART segment will grow at a faster CAGR over the assessment period.
Similarly, the growing popularity of modified IVF versions such as gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT) coupled with advancements in in-vitro fertilization monitoring (IVF) systems and expansion of assisted reproductive technology market across developed and developing regions will further support the growth of this segment.
Demand for Infertility Treatments Among Females Remains High
As per FMI, the female infertility treatment segment accounts for the largest revenue share in the global infertility market and the trend is likely to continue during the forecast period, owing to the high female infertility rate worldwide caused by obesity, unhealthy lifestyle, and disorders like polycystic ovary syndrome (PCOS).
However, the increasing incidence of male sterility and the rapid expansion of the male infertility treatment market is expected to generate growth opportunities in the male infertility treatment segment during the forecast period.
Infertility Centers Becoming Ideal Destination for Infertility Treatments
Based on end-user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. Among these, the fertility centers segment dominated the global infertility treatment market in 2021 and is likely to retain its top position during the forecast period. The rapid surge in the number of fertility centers worldwide, the presence of advanced reproductive technologies in fertility centers, and various attractive infertility treatment packages offered by these fertility centers are triggering the growth of this segment.
Fertility centers deal with both natural remedies and medical treatment to increase sperm count, thereby becoming the first choice for male patients.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Leading infertility treatment providers are continuously focusing on expanding their infertility treatment product offerings and services to woo more and more customers. Further, they have adopted various strategies such as partnerships, acquisitions, mergers collaborations, the launch of awareness campaigns and advertisements, and the establishment of new infertility treatment centers and clinics to gain a competitive edge in the global infertility treatment market. For instance,
FMI’s latest infertility treatment market report analyzes the historical and present-day scenario of the global infertility treatment market to accurately gauge its potential future development. It highlights the key market dynamics including revenue growth drivers, restraints, opportunities, challenges, emerging market trends, product innovations, demand and supply graphs, and changing consumer preferences.
The report breaks down and analyzes the market segments to provide a better assessment of the top-scoring segments in the global infertility treatment market. It explains how the rise in infertility rates is igniting the demand for treatments like assisted reproductive technology.
FMI also attempts to highlight the impact of the flourishing in vitro fertilization market on the overall demand for infertility treatments and explains how the high success rate of IVF is giving hope to childless parents. The report has been interspersed with relevant statistics and graphs to make it more interesting.
The Infertility Treatment Market analysis includes:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | USD Million for Value and MT for Volume |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Key Segments Covered | Product Type, Procedure, Patient Type, End User, Region |
| Key regions covered | North America (USA, Canada, Rest of North America); Latin America (Brazil, Argentina, Mexico, Rest of Latin America); Western Europe (Germany, United Kingdom, France, Rest of Western Europe); Eastern Europe (Russia, Spain, Rest of Eastern Europe); South Asia Pacific (China, India, Japan, Malaysia, Thailand, Indonesia, South Korea, Rest of South Asia & Pacific); Middle East & Africa (GCC Countries, Turkey, Israel); Rest of the Middle East and Africa(MEA)); Rest of the World (Oceania, Africa, South America) |
| End User | Fertility Centre’s; Hospitals & Surgical Clinics; Cryobanks; Research Institutes |
| Key Companies Covered | Thermo Fisher Scientific (USA); Cook Group (USA); Vitrolife (Sweden); IVFtech APS (Denmark); Hamilton Thorne Ltd. (USA); Esco Micro Pte Ltd. (Singapore); Genea Biomedx Ltd. (Australia); FUJIFILM Irvine Scientific (USA); and the Baker Company INC. (USA) |
| Customization & Pricing | Available upon Request |
The global infertility market valuation reached over US$ 1.5 Billion in 2021.
As per FMI, global infertility treatment is likely to expand at 8% CAGR during the forecast period, totaling a valuation of US$ 3.5 Billion by 2032.
The Asia Pacific region is likely to continue dominating the global infertility market owing to the high adoption rate and growing health awareness among people.
Thermo Fisher Scientific (USA), Cook Group (USA), Vitrolife (Sweden), IVFtech APS (Denmark), Hamilton Thorne Ltd. (USA), Esco Micro Pte Ltd. (Singapore), Genea Biomedx Ltd. (Australia), FUJIFILM Irvine Scientific (USA), and the Baker Company INC. (USA) are some of the prominent market players operating in the infertility treatment market.
1. Executive Summary | Infertility Treatment Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage 2.2. Market Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in Optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2015 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Product, 2015 to 2021 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032 8.3.1. Equipment 8.3.1.1. Microscopes 8.3.1.2. Imaging Systems 8.3.1.3. Sperm Analyzer Systems 8.3.1.4. Ovum Aspiration Pumps 8.3.1.5. Micromanipulator Systems 8.3.1.6. Incubators 8.3.1.7. Gas Analyzers 8.3.1.8. Laser Systems 8.3.1.9. Cryosystems 8.3.1.10. Sperm Separation Devices 8.3.2. Media & Consumables 8.3.3. Accessories 8.4. Market Attractiveness Analysis By Product 9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Procedure 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Procedure, 2015 to 2021 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032 9.3.1. Assisted Reproductive Technology 9.3.1.1. In Vitro Fertilization 9.3.1.1.1. Intracytoplasmic Morphologically Selected Sperm Injection 9.3.1.1.2. Gamete Donation 9.3.1.2. Intracytoplasmic Sperm Injection 9.3.1.3. Surrogacy 9.3.2. Artificial Insemination 9.3.2.1. Intrauterine Insemination 9.3.2.2. Intracervical Insemination 9.3.2.3. Intratubal Insemination 9.3.3. Fertility Surgeries 9.3.3.1. Laparoscopy 9.3.3.2. Hysteroscopy 9.3.3.3. Varicocelectomy 9.3.3.4. Laparotomy 9.3.3.5. Tubal Ligation Reversal 9.3.3.6. Varicocelectomy 9.3.3.7. Microsurgical Reconstruction 9.3.3.7.1. Vasovasostomy 9.3.3.7.2. Vasoepididymostomy 9.3.4. Other Procedures 9.4. Market Attractiveness Analysis By Procedure 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Patient type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Patient Type, 2015 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Patient Type, 2022 to 2032 10.3.1. Female 10.3.2. Male 10.4. Market Attractiveness Analysis By Patient Type 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032 11.3.1. Fertility Centers 11.3.2. Hospitals & Surgical Clinics 11.3.3. Cryobanks 11.3.4. Research Institutes 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region 12.1. Introduction 12.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021 12.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. Asia Pacific 12.3.5. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. USA 13.4.1.2. Canada 13.4.1.3. Rest of North America 13.4.2. By Product 13.4.3. By Procedure 13.4.4. By End User 13.4.5. By Patient type 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product 13.5.3. By Procedure 13.5.4. By End User 13.5.5. By Patient type 14. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. Brazil 14.4.1.2. Mexico 14.4.1.3. Rest of Latin America 14.4.2. By Product 14.4.3. By Procedure 14.4.4. By End User 14.4.5. By Patient type 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.5.3. By Procedure 14.5.4. By End User 14.5.5. By Patient type 15. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. Germany 15.4.1.2. France 15.4.1.3. United Kingdom 15.4.1.4. Italy 15.4.1.5. Benelux 15.4.1.6. Nordic Countries 15.4.1.7. Rest of Europe 15.4.2. By Product 15.4.3. By Procedure 15.4.4. By End User 15.4.5. By Patient type 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By Procedure 15.5.4. By End User 15.5.5. By Patient type 16. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. China 16.4.1.2. Japan 16.4.1.3. South Korea 16.4.1.4. Rest of Asia Pacific 16.4.2. By Product 16.4.3. By Procedure 16.4.4. By End User 16.4.5. By Patient type 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By Procedure 16.5.4. By End User 16.5.5. By Patient type 17. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 17.4.1. By Country 17.4.1.1. GCC Countries 17.4.1.2. South Africa 17.4.1.3. Turkey 17.4.1.4. Rest of Middle East and Africa 17.4.2. By Product 17.4.3. By Procedure 17.4.4. By End User 17.4.5. By Patient type 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product 17.5.3. By Procedure 17.5.4. By End User 17.5.5. By Patient type 18. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. USA Market Analysis 18.2.1. Value Proportion Analysis by Market Taxonomy 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.2.2.1. By Product 18.2.2.2. By Procedure 18.2.2.3. By End User 18.2.2.4. By Patient type 18.3. Canada Market Analysis 18.3.1. Value Proportion Analysis by Market Taxonomy 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.3.2.1. By Product 18.3.2.2. By Procedure 18.3.2.3. By End User 18.3.2.4. By Patient type 18.4. Mexico Market Analysis 18.4.1. Value Proportion Analysis by Market Taxonomy 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.4.2.1. By Product 18.4.2.2. By Procedure 18.4.2.3. By End User 18.4.2.4. By Patient type 18.5. Brazil Market Analysis 18.5.1. Value Proportion Analysis by Market Taxonomy 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.5.2.1. By Product 18.5.2.2. By Procedure 18.5.2.3. By End User 18.5.2.4. By Patient type 18.6. Germany Market Analysis 18.6.1. Value Proportion Analysis by Market Taxonomy 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.6.2.1. By Product 18.6.2.2. By Procedure 18.6.2.3. By End User 18.6.2.4. By Patient type 18.7. France Market Analysis 18.7.1. Value Proportion Analysis by Market Taxonomy 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.7.2.1. By Product 18.7.2.2. By Procedure 18.7.2.3. By End User 18.7.2.4. By Patient type 18.8. Italy Market Analysis 18.8.1. Value Proportion Analysis by Market Taxonomy 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.8.2.1. By Product 18.8.2.2. By Procedure 18.8.2.3. By End User 18.8.2.4. By Patient type 18.9. BENELUX Market Analysis 18.9.1. Value Proportion Analysis by Market Taxonomy 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.9.2.1. By Product 18.9.2.2. By Procedure 18.9.2.3. By End User 18.9.2.4. By Patient type 18.10. United Kingdom Market Analysis 18.10.1. Value Proportion Analysis by Market Taxonomy 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.10.2.1. By Product 18.10.2.2. By Procedure 18.10.2.3. By End User 18.10.2.4. By Patient type 18.11. Nordic Countries Market Analysis 18.11.1. Value Proportion Analysis by Market Taxonomy 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.11.2.1. By Product 18.11.2.2. By Procedure 18.11.2.3. By End User 18.11.2.4. By Patient type 18.12. China Market Analysis 18.12.1. Value Proportion Analysis by Market Taxonomy 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.12.2.1. By Product 18.12.2.2. By Procedure 18.12.2.3. By End User 18.12.2.4. By Patient type 18.13. Japan Market Analysis 18.13.1. Value Proportion Analysis by Market Taxonomy 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.13.2.1. By Product 18.13.2.2. By Procedure 18.13.2.3. By End User 18.13.2.4. By Patient type 18.14. South Korea Market Analysis 18.14.1. Value Proportion Analysis by Market Taxonomy 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.14.2.1. By Product 18.14.2.2. By Procedure 18.14.2.3. By End User 18.14.2.4. By Patient type 18.15. GCC Countries Market Analysis 18.15.1. Value Proportion Analysis by Market Taxonomy 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.15.2.1. By Product 18.15.2.2. By Procedure 18.15.2.3. By End User 18.15.2.4. By Patient type 18.16. South Africa Market Analysis 18.16.1. Value Proportion Analysis by Market Taxonomy 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.16.2.1. By Product 18.16.2.2. By Procedure 18.16.2.3. By End User 18.16.2.4. By Patient type 18.17. Turkey Market Analysis 18.17.1. Value Proportion Analysis by Market Taxonomy 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032 18.17.2.1. By Product 18.17.2.2. By Procedure 18.17.2.3. By End User 18.17.2.4. By Patient type 18.17.3. Competition Landscape and Player Concentration in the Country 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional Footprint of Players 19.4.2. Product Footprint by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. The Cooper Companies, Inc. 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Sales Footprint 20.3.1.4. Strategy Overview 20.3.2. Cook Group 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Sales Footprint 20.3.2.4. Strategy Overview 20.3.3. Vitrolife 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Sales Footprint 20.3.3.4. Strategy Overview 20.3.4. Thermo Fisher Scientific 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Sales Footprint 20.3.4.4. Strategy Overview 20.3.5. Hamilton Thorne LTD 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Sales Footprint 20.3.5.4. Strategy Overview 20.3.6. Esco Micro Pte Ltd 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Sales Footprint 20.3.6.4. Strategy Overview 20.3.7. Genea Limited 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Sales Footprint 20.3.7.4. Strategy Overview 20.3.8. IVFtech APS 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Sales Footprint 20.3.8.4. Strategy Overview 20.3.9. FUJIFILM Irvine Scientific 20.3.9.1. Overview 20.3.9.2. Product Portfolio 20.3.9.3. Sales Footprint 20.3.9.4. Strategy Overview 20.3.10. The Baker Company INC 20.3.10.1. Overview 20.3.10.2. Product Portfolio 20.3.10.3. Sales Footprint 20.3.10.4. Strategy Overview 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Infertility Treatment Market
